Tranexamic Acid Injection, Solution
FDA Label NDC 70121-1398

32 label sections · Submitted to the FDA by Amneal Pharmaceuticals Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Llc for the product Tranexamic Acid (NDC 70121-1398). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: risk of medication errors due to incorrect route of administration, 1   indications and usage, 2.1  recommended dosage, 2.2  recommended dosage for patients with varying degrees of renal impairment, 2.3 preparation and administration, 3   dosage forms and strengths, 4    contraindications, 5.1   risk of medication errors due to incorrect route of administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.